Request for Covid-19 Impact Assessment of this Report
The United States Ketorolac Tromethamine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Ketorolac Tromethamine market, reaching US$ million by the year 2028. As for the Europe Ketorolac Tromethamine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Ketorolac Tromethamine players cover Pfizer, Omeros Corporation, Egalet US Inc., and Allergan, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Ketorolac Tromethamine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Injection
Ophthalmic
Nasal
Oral tablet
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Short-term treatment of pain
Ophthalmic Surgery
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Pfizer
Omeros Corporation
Egalet US Inc.
Allergan
Dr. Reddy’s Laboratories
Teva
Mylan
West Ward Pharmaceuticals
Fresenius Kabi
Apotex
Sandoz
Amphastar Pharmaceuticals
Gland Pharma Limited
Akorn
Sun Pharmaceutical
Sagent Pharmaceuticals
Aurobindo Pharma
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Ketorolac Tromethamine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Ketorolac Tromethamine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Ketorolac Tromethamine by Country/Region, 2017, 2022 & 2028
2.2 Ketorolac Tromethamine Segment by Type
2.2.1 Injection
2.2.2 Ophthalmic
2.2.3 Nasal
2.2.4 Oral tablet
2.3 Ketorolac Tromethamine Sales by Type
2.3.1 Global Ketorolac Tromethamine Sales Market Share by Type (2017-2022)
2.3.2 Global Ketorolac Tromethamine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Ketorolac Tromethamine Sale Price by Type (2017-2022)
2.4 Ketorolac Tromethamine Segment by Application
2.4.1 Short-term treatment of pain
2.4.2 Ophthalmic Surgery
2.5 Ketorolac Tromethamine Sales by Application
2.5.1 Global Ketorolac Tromethamine Sale Market Share by Application (2017-2022)
2.5.2 Global Ketorolac Tromethamine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Ketorolac Tromethamine Sale Price by Application (2017-2022)
3 Global Ketorolac Tromethamine by Company
3.1 Global Ketorolac Tromethamine Breakdown Data by Company
3.1.1 Global Ketorolac Tromethamine Annual Sales by Company (2020-2022)
3.1.2 Global Ketorolac Tromethamine Sales Market Share by Company (2020-2022)
3.2 Global Ketorolac Tromethamine Annual Revenue by Company (2020-2022)
3.2.1 Global Ketorolac Tromethamine Revenue by Company (2020-2022)
3.2.2 Global Ketorolac Tromethamine Revenue Market Share by Company (2020-2022)
3.3 Global Ketorolac Tromethamine Sale Price by Company
3.4 Key Manufacturers Ketorolac Tromethamine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Ketorolac Tromethamine Product Location Distribution
3.4.2 Players Ketorolac Tromethamine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Ketorolac Tromethamine by Geographic Region
4.1 World Historic Ketorolac Tromethamine Market Size by Geographic Region (2017-2022)
4.1.1 Global Ketorolac Tromethamine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Ketorolac Tromethamine Annual Revenue by Geographic Region
4.2 World Historic Ketorolac Tromethamine Market Size by Country/Region (2017-2022)
4.2.1 Global Ketorolac Tromethamine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Ketorolac Tromethamine Annual Revenue by Country/Region
4.3 Americas Ketorolac Tromethamine Sales Growth
4.4 APAC Ketorolac Tromethamine Sales Growth
4.5 Europe Ketorolac Tromethamine Sales Growth
4.6 Middle East & Africa Ketorolac Tromethamine Sales Growth
5 Americas
5.1 Americas Ketorolac Tromethamine Sales by Country
5.1.1 Americas Ketorolac Tromethamine Sales by Country (2017-2022)
5.1.2 Americas Ketorolac Tromethamine Revenue by Country (2017-2022)
5.2 Americas Ketorolac Tromethamine Sales by Type
5.3 Americas Ketorolac Tromethamine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ketorolac Tromethamine Sales by Region
6.1.1 APAC Ketorolac Tromethamine Sales by Region (2017-2022)
6.1.2 APAC Ketorolac Tromethamine Revenue by Region (2017-2022)
6.2 APAC Ketorolac Tromethamine Sales by Type
6.3 APAC Ketorolac Tromethamine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Ketorolac Tromethamine by Country
7.1.1 Europe Ketorolac Tromethamine Sales by Country (2017-2022)
7.1.2 Europe Ketorolac Tromethamine Revenue by Country (2017-2022)
7.2 Europe Ketorolac Tromethamine Sales by Type
7.3 Europe Ketorolac Tromethamine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Ketorolac Tromethamine by Country
8.1.1 Middle East & Africa Ketorolac Tromethamine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Ketorolac Tromethamine Revenue by Country (2017-2022)
8.2 Middle East & Africa Ketorolac Tromethamine Sales by Type
8.3 Middle East & Africa Ketorolac Tromethamine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Ketorolac Tromethamine
10.3 Manufacturing Process Analysis of Ketorolac Tromethamine
10.4 Industry Chain Structure of Ketorolac Tromethamine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Ketorolac Tromethamine Distributors
11.3 Ketorolac Tromethamine Customer
12 World Forecast Review for Ketorolac Tromethamine by Geographic Region
12.1 Global Ketorolac Tromethamine Market Size Forecast by Region
12.1.1 Global Ketorolac Tromethamine Forecast by Region (2023-2028)
12.1.2 Global Ketorolac Tromethamine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Ketorolac Tromethamine Forecast by Type
12.7 Global Ketorolac Tromethamine Forecast by Application
13 Key Players Analysis
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Ketorolac Tromethamine Product Offered
13.1.3 Pfizer Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Omeros Corporation
13.2.1 Omeros Corporation Company Information
13.2.2 Omeros Corporation Ketorolac Tromethamine Product Offered
13.2.3 Omeros Corporation Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Omeros Corporation Main Business Overview
13.2.5 Omeros Corporation Latest Developments
13.3 Egalet US Inc.
13.3.1 Egalet US Inc. Company Information
13.3.2 Egalet US Inc. Ketorolac Tromethamine Product Offered
13.3.3 Egalet US Inc. Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Egalet US Inc. Main Business Overview
13.3.5 Egalet US Inc. Latest Developments
13.4 Allergan
13.4.1 Allergan Company Information
13.4.2 Allergan Ketorolac Tromethamine Product Offered
13.4.3 Allergan Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Allergan Main Business Overview
13.4.5 Allergan Latest Developments
13.5 Dr. Reddy’s Laboratories
13.5.1 Dr. Reddy’s Laboratories Company Information
13.5.2 Dr. Reddy’s Laboratories Ketorolac Tromethamine Product Offered
13.5.3 Dr. Reddy’s Laboratories Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Dr. Reddy’s Laboratories Main Business Overview
13.5.5 Dr. Reddy’s Laboratories Latest Developments
13.6 Teva
13.6.1 Teva Company Information
13.6.2 Teva Ketorolac Tromethamine Product Offered
13.6.3 Teva Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Teva Main Business Overview
13.6.5 Teva Latest Developments
13.7 Mylan
13.7.1 Mylan Company Information
13.7.2 Mylan Ketorolac Tromethamine Product Offered
13.7.3 Mylan Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Mylan Main Business Overview
13.7.5 Mylan Latest Developments
13.8 West Ward Pharmaceuticals
13.8.1 West Ward Pharmaceuticals Company Information
13.8.2 West Ward Pharmaceuticals Ketorolac Tromethamine Product Offered
13.8.3 West Ward Pharmaceuticals Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 West Ward Pharmaceuticals Main Business Overview
13.8.5 West Ward Pharmaceuticals Latest Developments
13.9 Fresenius Kabi
13.9.1 Fresenius Kabi Company Information
13.9.2 Fresenius Kabi Ketorolac Tromethamine Product Offered
13.9.3 Fresenius Kabi Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Fresenius Kabi Main Business Overview
13.9.5 Fresenius Kabi Latest Developments
13.10 Apotex
13.10.1 Apotex Company Information
13.10.2 Apotex Ketorolac Tromethamine Product Offered
13.10.3 Apotex Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Apotex Main Business Overview
13.10.5 Apotex Latest Developments
13.11 Sandoz
13.11.1 Sandoz Company Information
13.11.2 Sandoz Ketorolac Tromethamine Product Offered
13.11.3 Sandoz Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Sandoz Main Business Overview
13.11.5 Sandoz Latest Developments
13.12 Amphastar Pharmaceuticals
13.12.1 Amphastar Pharmaceuticals Company Information
13.12.2 Amphastar Pharmaceuticals Ketorolac Tromethamine Product Offered
13.12.3 Amphastar Pharmaceuticals Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Amphastar Pharmaceuticals Main Business Overview
13.12.5 Amphastar Pharmaceuticals Latest Developments
13.13 Gland Pharma Limited
13.13.1 Gland Pharma Limited Company Information
13.13.2 Gland Pharma Limited Ketorolac Tromethamine Product Offered
13.13.3 Gland Pharma Limited Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Gland Pharma Limited Main Business Overview
13.13.5 Gland Pharma Limited Latest Developments
13.14 Akorn
13.14.1 Akorn Company Information
13.14.2 Akorn Ketorolac Tromethamine Product Offered
13.14.3 Akorn Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Akorn Main Business Overview
13.14.5 Akorn Latest Developments
13.15 Sun Pharmaceutical
13.15.1 Sun Pharmaceutical Company Information
13.15.2 Sun Pharmaceutical Ketorolac Tromethamine Product Offered
13.15.3 Sun Pharmaceutical Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Sun Pharmaceutical Main Business Overview
13.15.5 Sun Pharmaceutical Latest Developments
13.16 Sagent Pharmaceuticals
13.16.1 Sagent Pharmaceuticals Company Information
13.16.2 Sagent Pharmaceuticals Ketorolac Tromethamine Product Offered
13.16.3 Sagent Pharmaceuticals Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Sagent Pharmaceuticals Main Business Overview
13.16.5 Sagent Pharmaceuticals Latest Developments
13.17 Aurobindo Pharma
13.17.1 Aurobindo Pharma Company Information
13.17.2 Aurobindo Pharma Ketorolac Tromethamine Product Offered
13.17.3 Aurobindo Pharma Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Aurobindo Pharma Main Business Overview
13.17.5 Aurobindo Pharma Latest Developments
14 Research Findings and Conclusion
Table 1. Ketorolac Tromethamine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Ketorolac Tromethamine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Injection
Table 4. Major Players of Ophthalmic
Table 5. Major Players of Nasal
Table 6. Major Players of Oral tablet
Table 7. Global Ketorolac Tromethamine Sales by Type (2017-2022) & (K Units)
Table 8. Global Ketorolac Tromethamine Sales Market Share by Type (2017-2022)
Table 9. Global Ketorolac Tromethamine Revenue by Type (2017-2022) & ($ million)
Table 10. Global Ketorolac Tromethamine Revenue Market Share by Type (2017-2022)
Table 11. Global Ketorolac Tromethamine Sale Price by Type (2017-2022) & (USD/Unit)
Table 12. Global Ketorolac Tromethamine Sales by Application (2017-2022) & (K Units)
Table 13. Global Ketorolac Tromethamine Sales Market Share by Application (2017-2022)
Table 14. Global Ketorolac Tromethamine Revenue by Application (2017-2022)
Table 15. Global Ketorolac Tromethamine Revenue Market Share by Application (2017-2022)
Table 16. Global Ketorolac Tromethamine Sale Price by Application (2017-2022) & (USD/Unit)
Table 17. Global Ketorolac Tromethamine Sales by Company (2020-2022) & (K Units)
Table 18. Global Ketorolac Tromethamine Sales Market Share by Company (2020-2022)
Table 19. Global Ketorolac Tromethamine Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Ketorolac Tromethamine Revenue Market Share by Company (2020-2022)
Table 21. Global Ketorolac Tromethamine Sale Price by Company (2020-2022) & (USD/Unit)
Table 22. Key Manufacturers Ketorolac Tromethamine Producing Area Distribution and Sales Area
Table 23. Players Ketorolac Tromethamine Products Offered
Table 24. Ketorolac Tromethamine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Ketorolac Tromethamine Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global Ketorolac Tromethamine Sales Market Share Geographic Region (2017-2022)
Table 29. Global Ketorolac Tromethamine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Ketorolac Tromethamine Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Ketorolac Tromethamine Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global Ketorolac Tromethamine Sales Market Share by Country/Region (2017-2022)
Table 33. Global Ketorolac Tromethamine Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Ketorolac Tromethamine Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Ketorolac Tromethamine Sales by Country (2017-2022) & (K Units)
Table 36. Americas Ketorolac Tromethamine Sales Market Share by Country (2017-2022)
Table 37. Americas Ketorolac Tromethamine Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Ketorolac Tromethamine Revenue Market Share by Country (2017-2022)
Table 39. Americas Ketorolac Tromethamine Sales by Type (2017-2022) & (K Units)
Table 40. Americas Ketorolac Tromethamine Sales Market Share by Type (2017-2022)
Table 41. Americas Ketorolac Tromethamine Sales by Application (2017-2022) & (K Units)
Table 42. Americas Ketorolac Tromethamine Sales Market Share by Application (2017-2022)
Table 43. APAC Ketorolac Tromethamine Sales by Region (2017-2022) & (K Units)
Table 44. APAC Ketorolac Tromethamine Sales Market Share by Region (2017-2022)
Table 45. APAC Ketorolac Tromethamine Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Ketorolac Tromethamine Revenue Market Share by Region (2017-2022)
Table 47. APAC Ketorolac Tromethamine Sales by Type (2017-2022) & (K Units)
Table 48. APAC Ketorolac Tromethamine Sales Market Share by Type (2017-2022)
Table 49. APAC Ketorolac Tromethamine Sales by Application (2017-2022) & (K Units)
Table 50. APAC Ketorolac Tromethamine Sales Market Share by Application (2017-2022)
Table 51. Europe Ketorolac Tromethamine Sales by Country (2017-2022) & (K Units)
Table 52. Europe Ketorolac Tromethamine Sales Market Share by Country (2017-2022)
Table 53. Europe Ketorolac Tromethamine Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Ketorolac Tromethamine Revenue Market Share by Country (2017-2022)
Table 55. Europe Ketorolac Tromethamine Sales by Type (2017-2022) & (K Units)
Table 56. Europe Ketorolac Tromethamine Sales Market Share by Type (2017-2022)
Table 57. Europe Ketorolac Tromethamine Sales by Application (2017-2022) & (K Units)
Table 58. Europe Ketorolac Tromethamine Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Ketorolac Tromethamine Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa Ketorolac Tromethamine Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Ketorolac Tromethamine Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Ketorolac Tromethamine Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Ketorolac Tromethamine Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa Ketorolac Tromethamine Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Ketorolac Tromethamine Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa Ketorolac Tromethamine Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Ketorolac Tromethamine
Table 68. Key Market Challenges & Risks of Ketorolac Tromethamine
Table 69. Key Industry Trends of Ketorolac Tromethamine
Table 70. Ketorolac Tromethamine Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Ketorolac Tromethamine Distributors List
Table 73. Ketorolac Tromethamine Customer List
Table 74. Global Ketorolac Tromethamine Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global Ketorolac Tromethamine Sales Market Forecast by Region
Table 76. Global Ketorolac Tromethamine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Ketorolac Tromethamine Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Ketorolac Tromethamine Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas Ketorolac Tromethamine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Ketorolac Tromethamine Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC Ketorolac Tromethamine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Ketorolac Tromethamine Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe Ketorolac Tromethamine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Ketorolac Tromethamine Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa Ketorolac Tromethamine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Ketorolac Tromethamine Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global Ketorolac Tromethamine Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Ketorolac Tromethamine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Ketorolac Tromethamine Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Ketorolac Tromethamine Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global Ketorolac Tromethamine Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Ketorolac Tromethamine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Ketorolac Tromethamine Revenue Market Share Forecast by Application (2023-2028)
Table 94. Pfizer Basic Information, Ketorolac Tromethamine Manufacturing Base, Sales Area and Its Competitors
Table 95. Pfizer Ketorolac Tromethamine Product Offered
Table 96. Pfizer Ketorolac Tromethamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 97. Pfizer Main Business
Table 98. Pfizer Latest Developments
Table 99. Omeros Corporation Basic Information, Ketorolac Tromethamine Manufacturing Base, Sales Area and Its Competitors
Table 100. Omeros Corporation Ketorolac Tromethamine Product Offered
Table 101. Omeros Corporation Ketorolac Tromethamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 102. Omeros Corporation Main Business
Table 103. Omeros Corporation Latest Developments
Table 104. Egalet US Inc. Basic Information, Ketorolac Tromethamine Manufacturing Base, Sales Area and Its Competitors
Table 105. Egalet US Inc. Ketorolac Tromethamine Product Offered
Table 106. Egalet US Inc. Ketorolac Tromethamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 107. Egalet US Inc. Main Business
Table 108. Egalet US Inc. Latest Developments
Table 109. Allergan Basic Information, Ketorolac Tromethamine Manufacturing Base, Sales Area and Its Competitors
Table 110. Allergan Ketorolac Tromethamine Product Offered
Table 111. Allergan Ketorolac Tromethamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 112. Allergan Main Business
Table 113. Allergan Latest Developments
Table 114. Dr. Reddy’s Laboratories Basic Information, Ketorolac Tromethamine Manufacturing Base, Sales Area and Its Competitors
Table 115. Dr. Reddy’s Laboratories Ketorolac Tromethamine Product Offered
Table 116. Dr. Reddy’s Laboratories Ketorolac Tromethamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 117. Dr. Reddy’s Laboratories Main Business
Table 118. Dr. Reddy’s Laboratories Latest Developments
Table 119. Teva Basic Information, Ketorolac Tromethamine Manufacturing Base, Sales Area and Its Competitors
Table 120. Teva Ketorolac Tromethamine Product Offered
Table 121. Teva Ketorolac Tromethamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 122. Teva Main Business
Table 123. Teva Latest Developments
Table 124. Mylan Basic Information, Ketorolac Tromethamine Manufacturing Base, Sales Area and Its Competitors
Table 125. Mylan Ketorolac Tromethamine Product Offered
Table 126. Mylan Ketorolac Tromethamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 127. Mylan Main Business
Table 128. Mylan Latest Developments
Table 129. West Ward Pharmaceuticals Basic Information, Ketorolac Tromethamine Manufacturing Base, Sales Area and Its Competitors
Table 130. West Ward Pharmaceuticals Ketorolac Tromethamine Product Offered
Table 131. West Ward Pharmaceuticals Ketorolac Tromethamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 132. West Ward Pharmaceuticals Main Business
Table 133. West Ward Pharmaceuticals Latest Developments
Table 134. Fresenius Kabi Basic Information, Ketorolac Tromethamine Manufacturing Base, Sales Area and Its Competitors
Table 135. Fresenius Kabi Ketorolac Tromethamine Product Offered
Table 136. Fresenius Kabi Ketorolac Tromethamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 137. Fresenius Kabi Main Business
Table 138. Fresenius Kabi Latest Developments
Table 139. Apotex Basic Information, Ketorolac Tromethamine Manufacturing Base, Sales Area and Its Competitors
Table 140. Apotex Ketorolac Tromethamine Product Offered
Table 141. Apotex Ketorolac Tromethamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 142. Apotex Main Business
Table 143. Apotex Latest Developments
Table 144. Sandoz Basic Information, Ketorolac Tromethamine Manufacturing Base, Sales Area and Its Competitors
Table 145. Sandoz Ketorolac Tromethamine Product Offered
Table 146. Sandoz Ketorolac Tromethamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 147. Sandoz Main Business
Table 148. Sandoz Latest Developments
Table 149. Amphastar Pharmaceuticals Basic Information, Ketorolac Tromethamine Manufacturing Base, Sales Area and Its Competitors
Table 150. Amphastar Pharmaceuticals Ketorolac Tromethamine Product Offered
Table 151. Amphastar Pharmaceuticals Ketorolac Tromethamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 152. Amphastar Pharmaceuticals Main Business
Table 153. Amphastar Pharmaceuticals Latest Developments
Table 154. Gland Pharma Limited Basic Information, Ketorolac Tromethamine Manufacturing Base, Sales Area and Its Competitors
Table 155. Gland Pharma Limited Ketorolac Tromethamine Product Offered
Table 156. Gland Pharma Limited Ketorolac Tromethamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 157. Gland Pharma Limited Main Business
Table 158. Gland Pharma Limited Latest Developments
Table 159. Akorn Basic Information, Ketorolac Tromethamine Manufacturing Base, Sales Area and Its Competitors
Table 160. Akorn Ketorolac Tromethamine Product Offered
Table 161. Akorn Ketorolac Tromethamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 162. Akorn Main Business
Table 163. Akorn Latest Developments
Table 164. Sun Pharmaceutical Basic Information, Ketorolac Tromethamine Manufacturing Base, Sales Area and Its Competitors
Table 165. Sun Pharmaceutical Ketorolac Tromethamine Product Offered
Table 166. Sun Pharmaceutical Ketorolac Tromethamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 167. Sun Pharmaceutical Main Business
Table 168. Sun Pharmaceutical Latest Developments
Table 169. Sagent Pharmaceuticals Basic Information, Ketorolac Tromethamine Manufacturing Base, Sales Area and Its Competitors
Table 170. Sagent Pharmaceuticals Ketorolac Tromethamine Product Offered
Table 171. Sagent Pharmaceuticals Ketorolac Tromethamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 172. Sagent Pharmaceuticals Main Business
Table 173. Sagent Pharmaceuticals Latest Developments
Table 174. Aurobindo Pharma Basic Information, Ketorolac Tromethamine Manufacturing Base, Sales Area and Its Competitors
Table 175. Aurobindo Pharma Ketorolac Tromethamine Product Offered
Table 176. Aurobindo Pharma Ketorolac Tromethamine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 177. Aurobindo Pharma Main Business
Table 178. Aurobindo Pharma Latest Developments
List of Figures
Figure 1. Picture of Ketorolac Tromethamine
Figure 2. Ketorolac Tromethamine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Ketorolac Tromethamine Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Ketorolac Tromethamine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Ketorolac Tromethamine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Injection
Figure 10. Product Picture of Ophthalmic
Figure 11. Product Picture of Nasal
Figure 12. Product Picture of Oral tablet
Figure 13. Global Ketorolac Tromethamine Sales Market Share by Type in 2021
Figure 14. Global Ketorolac Tromethamine Revenue Market Share by Type (2017-2022)
Figure 15. Ketorolac Tromethamine Consumed in Short-term treatment of pain
Figure 16. Global Ketorolac Tromethamine Market: Short-term treatment of pain (2017-2022) & (K Units)
Figure 17. Ketorolac Tromethamine Consumed in Ophthalmic Surgery
Figure 18. Global Ketorolac Tromethamine Market: Ophthalmic Surgery (2017-2022) & (K Units)
Figure 19. Global Ketorolac Tromethamine Sales Market Share by Application (2017-2022)
Figure 20. Global Ketorolac Tromethamine Revenue Market Share by Application in 2021
Figure 21. Ketorolac Tromethamine Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Ketorolac Tromethamine Revenue Market Share by Company in 2021
Figure 23. Global Ketorolac Tromethamine Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Ketorolac Tromethamine Revenue Market Share by Geographic Region in 2021
Figure 25. Global Ketorolac Tromethamine Sales Market Share by Region (2017-2022)
Figure 26. Global Ketorolac Tromethamine Revenue Market Share by Country/Region in 2021
Figure 27. Americas Ketorolac Tromethamine Sales 2017-2022 (K Units)
Figure 28. Americas Ketorolac Tromethamine Revenue 2017-2022 ($ Millions)
Figure 29. APAC Ketorolac Tromethamine Sales 2017-2022 (K Units)
Figure 30. APAC Ketorolac Tromethamine Revenue 2017-2022 ($ Millions)
Figure 31. Europe Ketorolac Tromethamine Sales 2017-2022 (K Units)
Figure 32. Europe Ketorolac Tromethamine Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Ketorolac Tromethamine Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Ketorolac Tromethamine Revenue 2017-2022 ($ Millions)
Figure 35. Americas Ketorolac Tromethamine Sales Market Share by Country in 2021
Figure 36. Americas Ketorolac Tromethamine Revenue Market Share by Country in 2021
Figure 37. United States Ketorolac Tromethamine Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Ketorolac Tromethamine Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Ketorolac Tromethamine Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Ketorolac Tromethamine Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Ketorolac Tromethamine Sales Market Share by Region in 2021
Figure 42. APAC Ketorolac Tromethamine Revenue Market Share by Regions in 2021
Figure 43. China Ketorolac Tromethamine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Ketorolac Tromethamine Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Ketorolac Tromethamine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Ketorolac Tromethamine Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Ketorolac Tromethamine Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Ketorolac Tromethamine Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Ketorolac Tromethamine Sales Market Share by Country in 2021
Figure 50. Europe Ketorolac Tromethamine Revenue Market Share by Country in 2021
Figure 51. Germany Ketorolac Tromethamine Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Ketorolac Tromethamine Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Ketorolac Tromethamine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Ketorolac Tromethamine Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Ketorolac Tromethamine Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Ketorolac Tromethamine Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Ketorolac Tromethamine Revenue Market Share by Country in 2021
Figure 58. Egypt Ketorolac Tromethamine Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Ketorolac Tromethamine Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Ketorolac Tromethamine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Ketorolac Tromethamine Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Ketorolac Tromethamine Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Ketorolac Tromethamine in 2021
Figure 64. Manufacturing Process Analysis of Ketorolac Tromethamine
Figure 65. Industry Chain Structure of Ketorolac Tromethamine
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...